WDNAvsTMEDETF Comparison
WisdomTree BioRevolution Fund (WDNA) belongs to the BioTech & Genomics segment. T. Rowe Price Health Care ETF (TMED) is part of the US Health Care segment. WDNA's top 3 sector exposures are Health Care, Materials and Consumer Staples. In contrast, TMED's top sector exposures are Health Care, Financials WDNA is more expensive with a Total Expense Ratio (TER) of 0.45%, versus 0.44% for TMED. WDNA is up 4.07% year-to-date (YTD) with -$357K in YTD flows. TMED performs worse with -0.2% YTD performance, and +$3M in YTD flows. Run a side-by-side ETF comparison of WDNA and TMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
WDNA vs TMED performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | WDNA TMED | +5.33%+7.12% | -3.11%-1.63% | +4.07%-0.20% | +40.90%n/a | +9.37%n/a | n/an/a |
| Flows | WDNA TMED | --$41K | -$357K+$3M | -$357K+$3M | -$357K- | -$524K- | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | WDNA TMED | +23.61%+20.92% | +26.74%n/a | +24.79%n/a | n/an/a |
| Max drawdown | WDNA TMED | -9.30%-9.37% | -11.90%n/a | -37.80%n/a | n/an/a |
| Max drawdown duration | WDNA TMED | 49d46d | 96dn/a | 901dn/a | n/an/a |
WDNA | TMED | |
Last sale 4/28/2026 at 1:30 PM | $17.65 | $29.56 |
| Previous close 04/28/2026 | $17.70 | $29.63 |
| Consolidated volume 04/28/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
WDNA | TMED | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
WDNA | TMED | |
|---|---|---|
| Last price | $17.65 | $29.56 |
| 1D performance | -0.28% | -0.23% |
| AuM | $2.29 M | $19.25 M |
| E/R | 0.45% | 0.44% |
WDNA | TMED | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | WisdomTree | T. Rowe Price |
| Benchmark | WisdomTree BioRevolution Index | - |
| N° of holdings | 75 | 76 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 3, 2021 | June 11, 2025 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
